Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Stauber

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy. Methods & Clinical Development|July 14, 2018
Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in AtherosclerosisSilvia Aldi, Ljubica Perisic Matic, Gregory Hamm, et al.
Acta Neuropathologica Communications|November 21, 2013
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KGAnna C Navis, Simone P Niclou, Fred Fack, et al.
Autophagy|November 6, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functionsSonia Brun, Eloïne Bestion, Eric Raymond, et al.
The Journal of Clinical Investigation|May 10, 2022
Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcriptionIsabel Paiva, Lucrezia Cellai, Céline Meriaux, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy. Methods & Clinical Development|July 14, 2018
Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in AtherosclerosisSilvia Aldi, Ljubica Perisic Matic, Gregory Hamm, et al.
Acta Neuropathologica Communications|November 21, 2013
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KGAnna C Navis, Simone P Niclou, Fred Fack, et al.
Autophagy|November 6, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functionsSonia Brun, Eloïne Bestion, Eric Raymond, et al.
The Journal of Clinical Investigation|May 10, 2022
Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcriptionIsabel Paiva, Lucrezia Cellai, Céline Meriaux, et al.
Pageof 4